Yahoo
BSE - Delayed Quote INR

Anuh Pharma Limited (ANUHPHR.BO)

84.53 -2.56 (-2.94%)
At close: 3:29:31 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2026 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
Name Title Pay Exercised Year Born
Mr. Ritesh Bipin Shah MBA
Joint MD & Executive Director 8.23M -- 1981
Mr. Vivek Bipin Shah M.Sc
Joint MD & Executive Director 8.25M -- 1986
Mr. Bipin Nemchand Shah
Non-Executive Vice Chairman of the Board 490k -- 1949
Mr. Darshan Dhirajlal Rampariya
Chief Financial Officer 4.64M -- --
Mr. Manan Jayesh Vadhan
Company Secretary & Compliance Officer 1.04M -- --
Mr. Babu K. Moghaveera
Assistant General Manager of Technical -- -- --
Mr. Amit R. Saratkar
Assistant General Manager of HR Strategy and Transformation -- -- --
Mr. Rajendrakumar C. Kotadia
Chief Marketing Officer of Emerging Markets -- -- 1964
Mr. Bijal Kaushal H. Shroff
Regional Head of India, SAARC & MENA -- -- --
Mr. Vinayak Shenoy
Chief Marketing Officer of Mature Markets -- -- --

Anuh Pharma Limited

3-A, Shivsagar Estate
North Wing Dr. Annie Besant Road Worli
Mumbai, 400018
India
91 22 6622 7575 https://www.anuhpharma.com
Sector: 
Healthcare
Full Time Employees: 
323

Description

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-malarial, anti-hypertension, expectorant, anti-diabetics, anti-bacterial, anti-gout, anti asthmatics, quinolones, anti biotic, anti platelet, anti-histamines, and intermediates; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, and anti-mitotic. The company also develops products, such as anticoagulant, antagonist, anti convulsants, anty-ulcerative, anty-ulcerative, anticholinergics, anti-anemic, antidepressant, and mucolytic agents. It also exports its products. Anuh Pharma Limited was incorporated in 1960 and is headquartered in Mumbai, India.

Corporate Governance

Anuh Pharma Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

August 5, 2026 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: